IN3 Summit 2010

NeoVista, Inc.

Fremont, CA

NeoVista, Inc. has a minimally invasive surgical technology that uses ionizing radiation to treat Age-Related Macular Degeneration (ARMD).

Endoscape, Inc.

Sunnyvale, CA

Endoscape is a fabless medical device company with Direct-to-Consumer strategy centered on the concept of "Walk-in Clinics for Colon Prep and Screening Colonoscopy Services at Retail (Convenient Care) Locations”.

Silicon Valley Medical Instruments

First Time Presenter

Fremont, CA

SVMI is a privately held, development stage company, focused on high definition intravascular ultrasound imaging and real time image guidance of least invasive cardiovascular procedures.

PolyMedix, Inc.

Radnor, PA

PolyMedix is developing novel, first in class therapies for serious, life threatening, acute disorders.

CytoPherx, Inc.

Ann Arbor, MI

Inflammation-based diseases and conditions with a proprietary selective cytopheresis system.

ThermopeutiX, Inc.

San Diego, CA

THERMOPEUTIX, INC has developed a proprietary catheter system/ treatment for ischemic brain injury. Primary markets are cardiac arrest, acute stroke and trauma.

Chesson Labs

Durham, NC

All of Chesson Labs products cleared for market and in development are based on this patented and patent-pending polymer formulation.

e-Zassi, LLC

Fernandina Beach, FL

InnoVision first look software enables medical device focused organizations to rapidly attract, screen and select the most synergistic and commercially-viable medical device technologies to deliver first mover advantages.

Neuravi Ltd.

Galway, Ireland

Neuravi is a start up medical device company focused on the treatment of acute ischemic stroke.

NovaScan, LLC

First Time Presenter

Milwaukee, WI

NovaScan’s FastPath hand held IntraOperative Surgical Probe is used in the diagnosis, staging & treatment of Breast Cancer, reducing the up to 40% incidence of repeat surgery reported in Breast Cancer Lumpectomy Surgery.

SeptRx, Inc.

First Time Presenter

Fremont, CA

SeptRx, Inc. is a cardiovascular device company developing innovative treatments for structural heart defects such as patent foramen ovale (PFO).

KC BioMedix

First Time Presenter

Shawnee, KS

KC BioMedix is a commercial stage medical device company developing and selling neurostimulation products that solve incompetent feeding issues in premature infants.

Micro-Imaging Solutions

Englewood, CO

Protected technology related to the development and utilization of miniature, high-resolution, low cost CMOS image sensors developed primarily for use in disposable endoscopic surgical applications.

LightIntegra

First Time Presenter

Vancouver, Canada

LightIntegra is developing ThromboLUX, a medical device that analyzes the quality of platelets immediately prior to a transfusion. ThromoboLUX will be the first point of care device able to give a rapid determination of platelet quality through a multi-dimensional test, thus avoiding the use of poor quality platelets and improving transfusion outcome.

Viveve, Inc.

First Time Presenter

Palo Alto, CA

Women's sexual health company developing a minimally invasive procedure to reverse some of the physical effects of vaginal childbirth.

PEAK Surgical, Inc.

Palo Alto, CA

Technology provides the precision of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral tissue damage.

FlowMedic, Ltd.

First Time Presenter

San Mateo, CA

World's smallest leg compression device for Deep Vein Thrombosis (DVT) prevention in surgical patients. Offers increased safety compared to currently used drugs (Lovenox) and may offer significant savings once replacing the use of drugs.

SpineAlign Medical Inc.

First Time Presenter

San Jose, CA

SpineAlign Medical is an early commercial stage medical device company dedicated to minimally invasive surgical products for Spine procedures.

CardiOx Corporation

Dublin, OH

CardiOx has developed, deployed into clinical trials, and is preparing to commercialize a non-invasive method for detecting the presence of a right-to–left cardiac shunt (i.e. PFO) to enable medical treatment and/or closure before the occurrence of a debilitating or life threatening stroke or heart attack.

Cequr, Ltd.

Hellerup, Denmark

CeQur's lead product candidate is a small, wearable insulin delivery device that delivers both basal and bolus doses subcutaneously. Its simple and discrete design enables patients to more easily comply with insulin regimens and experience the benefits of intensive insulin therapy.

Urovalve, Inc.

Newark, NJ

Urovalve is developing the Surinate® Bladder Management System, designed to improve the quality of life and reduce the number of health problems that men who suffer from acute or chronic urinary retention endure with conventional urinary catheter methods.

Regenesis Biomedical

Scottsdale, AZ

Marketing a device, Provant®, based on pulsed RF energy to trigger tissue regeneration-repair of soft tissues, including skin.

Ocular Therapeutix, Inc.

First Time Presenter

Bedford, MA

Ocular Therapeutix, Inc. is a privately held company focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology and ophthalmic surgery.

Bioheart, Inc.

Sunrise, FL

Bioheart's (BHRT.ob) flagship products are MyoCell a muscle stem cell composition and the MyoCath catheter system for treating advanced heart failure.

Leto Medical LLC

First Time Presenter

Fernandina Beach, FL

Leto Medical is developing a system of products based on an innovative electrical stimulation technology that will free individuals with colostomies from 24/7 dependence on an ostomy pouch.

Circuport

First Time Presenter

Morristown, NJ

The Circuport™ System provides a new direction in dialysis through a new mode of access through two implantable ports that allow safe repeated access into arteries and veins, so that the dialysis process works with the natural direction of blood flow.

Vital Access Corporation

Salt Lake City, UT

Vital Access is developing a proprietary technology that enables the percutaneous creation of a vascular anastomosis. We are utilizing this technology to improve long-term vascular access for dialysis and cancer patients.

MedExGen Inc.

First Time Presenter

Seoul, South Korea

A protein therapeutic R&D company owned 3 proprietary platform technologies for developing next generation biobetter drugs. 3 exemplary clinical trial candidates from them are belong to TNF inhibitors, erythropoietin and botulinum toxins. Better efficacy and safety plus longer duration of action are common features of them in rodent studies.

Vascular Access Technologies

First Time Presenter

Lebanon, NH

VAT has developed a proprietary IV catheter system which substantially increases successful IV insertions and provides top of class passive needle safety. This unique technology is also applicable to many other vascular access applications where higher success rates and less vessel trauma are important.

N8 Medical

First Time Presenter

Las Vegas, NV

N8 Medical is a privately-held company headquartered in Las Vegas, Nevada. It is dedicated to the prevention and cure of infectious disease.

CardioNexus Corp.

First Time Presenter

Houston, TX

CardioNexus Corp. is a new venture between Fairway Medical Technology and a Fortune 100 company focused on a breakthrough cardiovascular imaging technology for primary care physicians.

Neochord, Inc.

Minnetonka, MN

NeoChord is a mitral valve repair company whose device is used for implantation of artificial chordae tendinae ie "neo-chordae".

Harbor Medtech

First Time Presenter

Coto de Caza, CA

Company Description Coming Soon.